Clinical Trial Update: Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate) [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind trial in Parkinson's disease (early and moderate stages) has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-05-20